Tag: Hatch-Waxman Act

The Hatch-Waxman Act balances brand-name innovation with generic competition. Learn how ANDAs, the Orange Book, and patent challenges drive down drug costs.

Explore the cost differences between authorized generics and first-to-file generics. Learn how market exclusivity, FTC data, and competition impact drug prices for patients and pharmacies.

Explore the legal basis and FDA approval process for generic drugs, from the Hatch-Waxman Act and ANDA pathways to bioequivalence and patent challenges.

Learn how the FDA uses the ANDA process and bioequivalence testing to approve safe, affordable generic drugs under the Hatch-Waxman Act.